Search Results - "Naqvi, Fizza F"

Outcomes and risk stratification for late antibody-mediated rejection in recipients of ABO-incompatible kidney transplants: a retrospective study by Lonze, Bonnie E, Bae, Sunjae, Kraus, Edward S, Holechek, Mary J, King, Karen E, Alachkar, Nada, Naqvi, Fizza F, Dagher, Nabil N, Sharif, Adnan, Desai, Niraj M, Segev, Dorry L, Montgomery, Robert A

“…The required intensity of monitoring for antibody-mediated rejection (AMR) after of ABO-incompatible (ABOi) kidney transplantation is not clearly formulized…”
Get more information

Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus-Infected Donors to Noninfected Recipients: An Open-Label Nonrandomized Trial by Durand, Christine M, Bowring, Mary G, Brown, Diane M, Chattergoon, Michael A, Massaccesi, Guido, Bair, Nichole, Wesson, Russell, Reyad, Ashraf, Naqvi, Fizza F, Ostrander, Darin, Sugarman, Jeremy, Segev, Dorry L, Sulkowski, Mark, Desai, Niraj M

“…Given the high mortality rate for patients with end-stage kidney disease receiving dialysis and the efficacy and safety of hepatitis C virus (HCV) treatments,…”
Get full text

Preoperative Echocardiographic Differences and Transplant Outcomes Among Patients Receiving Simultaneous Liver-Kidney Versus Liver Transplant Alone by Mazumder, Nik R, Russell, Stuart D, Pustavoitau, Aliaksei, Chacko, Matthews, Rizkalla, Nicole, Saberi, Behnam, Philosophe, Benjamin, Cameron, Andrew M, Gurakar, Ahmet, Naqvi, Fizza F

“…Liver transplant and simultaneous liver-kidney transplant are major surgeries performed on high-risk individuals with end-stage liver disease and end-stage…”
Get full text

Four-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Hepatitis C-Viremic Donors to Hepatitis C-Negative Recipients: An Open-Label Nonrandomized Study by Durand, Christine M, Barnaba, Brittany, Yu, Sile, Brown, Diane M, Chattergoon, Michael A, Bair, Nichole, Naqvi, Fizza F, Sulkowski, Mark, Segev, Dorry L, Desai, Niraj M

Get full text

A prospective multicenter pilot study of HIV‐positive deceased donor to HIV‐positive recipient kidney transplantation: HOPE in action by Durand, Christine M., Zhang, Wanying, Brown, Diane M., Yu, Sile, Desai, Niraj, Redd, Andrew D., Bagnasco, Serena M., Naqvi, Fizza F., Seaman, Shanti, Doby, Brianna L., Ostrander, Darin, Bowring, Mary Grace, Eby, Yolanda, Fernandez, Reinaldo E., Friedman‐Moraco, Rachel, Turgeon, Nicole, Stock, Peter, Chin‐Hong, Peter, Mehta, Shikha, Stosor, Valentina, Small, Catherine B., Gupta, Gaurav, Mehta, Sapna A., Wolfe, Cameron R., Husson, Jennifer, Gilbert, Alexander, Cooper, Matthew, Adebiyi, Oluwafisayo, Agarwal, Avinash, Muller, Elmi, Quinn, Thomas C., Odim, Jonah, Huprikar, Shirish, Florman, Sander, Massie, Allan B., Tobian, Aaron A. R., Segev, Dorry L.

“…HIV‐positive donor to HIV‐positive recipient (HIV D+/R+) transplantation is permitted in the United States under the HIV Organ Policy Equity Act. To explore…”
Get full text

Kidney retransplantation after anti–programmed cell death‐1 (PD‐1)–related allograft rejection by Lipson, Evan J., Naqvi, Fizza F., Loss, Manisha J., Schollenberger, Megan D., Pardoll, Drew M., Moore, Jack, Brennan, Daniel C.

“…In this report, we describe the first kidney retransplantation performed after anti–programmed cell death‐1 (PD‐1)–related allograft rejection. In 2014, we…”
Get full text

Delayed Graft Function in Simultaneous Liver Kidney Transplantation by Weeks, Sharon R., Luo, Xun, Haugen, Christine E., Ottmann, Shane E., Gurakar, Ahmet O., Naqvi, Fizza F., Alqahtani, Saleh A., Philosophe, Benjamin, Cameron, Andrew M., Desai, Niraj M., Segev, Dorry L., Garonzik Wang, Jacqueline M.

“…BACKGROUND.Delayed graft function (DGF) is associated with inferior posttransplant outcomes in kidney transplantation. Given these adverse outcomes, we sought…”
Get full text

Steroid‐sparing maintenance immunosuppression is safe and effective after simultaneous liver‐kidney transplantation by Weeks, Sharon R., Luo, Xun, Toman, Lindsey, Gurakar, Ahmet O., Naqvi, Fizza F., Alqahtani, Saleh A., Philosophe, Benjamin, Cameron, Andrew M., Desai, Niraj M., Ottmann, Shane E., Segev, Dorry L., Garonzik‐Wang, Jacqueline

“…Optimization of maintenance immunosuppression (mIS) regimens in the transplant recipient requires a balance between sufficient potency to prevent rejection and…”
Get full text

Blood dendritic cell levels associated with impaired IL-12 production and T-cell deficiency in patients with kidney disease: implications for post-transplant viral infections by Chen, Ping, Sun, Qianmei, Huang, Yanfei, Atta, Mohamed G, Turban, Sharon, Segev, Dorry L, Marr, Kieren A, Naqvi, Fizza F, Alachkar, Nada, Kraus, Edward S, Womer, Karl L

“…Reduced pretransplant blood myeloid dendritic cell (mDC) levels are associated with post-transplant BK viremia and cytomegalovirus (CMV) disease after kidney…”
Get more information

Steroid-sparing maintenance immunosuppression is safe and effective after simultaneous liver-kidney transplantation by Weeks, Sharon R, Luo, Xun, Toman, Lindsey, Gurakar, Ahmet O, Naqvi, Fizza F, Alqahtani, Saleh A, Philosophe, Benjamin, Cameron, Andrew M, Desai, Niraj M, Ottmann, Shane E, Segev, Dorry L, Garonzik-Wang, Jacqueline

Get full text

Attitudes towards genetic diagnosis in Pakistan: a survey of medical and legal communities and parents of thalassemic children by Gilani, Ahmed I, Jadoon, Atif S, Qaiser, Rabia, Nasim, Sana, Meraj, Riffat, Nasir, Nosheen, Naqvi, Fizza F, Latif, Zafar, Memon, Muhammad A, Menezes, Esme V, Malik, Imran, Memon, Muhammad Z, Kazim, Syed F, Ahmad, Usman

“…It was the aim of this study to assess the attitudes of doctors, medical students, lawyers, parliament members and parents of thalassemic children towards…”
Get more information

A Case of Antibody-Mediated Rejection (ABMR) After Withdrawal of Etanercept in a Renal Transplant Recipient: PO2554 by Uy, Iris Jill E., Abuzeineh, Mohammad, Alasfar, Sami, Naqvi, Fizza F., Trollinger, Brandon L.

Get full text

Four-week direct-acting antiviral prophylaxis for kidney transplantation from hepatitis C-viremic donors to hepatitis C-negative recipients: An open-label non-randomized study by Durand, Christine M., Barnaba, Brittany, Yu, Sile, Brown, Diane M., Chattergoon, Michael A., Bair, Nichole, Naqvi, Fizza F., Sulkowski, Mark, Segev, Dorry L., Desai, Niraj M.

Get full text

Kidney retransplantation after anti-programmed cell death-1 (PD-1)-related allograft rejection by Lipson, Evan J, Naqvi, Fizza F, Loss, Manisha J, Schollenberger, Megan D, Pardoll, Drew M, Moore, Jack, Brennan, Daniel C

Get full text